Allison Patterson
Family · Tylertown, MSNPI 1386003937
Payments from drug & device makers
Across 249 payments — averaging $18.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$840
- AstraZeneca$599
- AbbVie$580
- GSK$299
- Lilly USA, LLC$250
- Novo Nordisk$209
- plus $2K from 25 others
What the payments were for
- Food & beverage$4,489100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 41 | $840 |
| AstraZeneca | 32 | $599 |
| AbbVie | 45 | $580 |
| GSK | 27 | $299 |
| Lilly USA, LLC | 13 | $250 |
| Novo Nordisk | 13 | $209 |
| Novartis | 8 | $166 |
| Astellas Pharma US Inc | 7 | $138 |
| Abiomed | 1 | $132 |
| Merck | 5 | $123 |
| Exact Sciences | 6 | $119 |
| E.r. Squibb & Sons, L.L.C. | 1 | $116 |
| Boehringer Ingelheim | 7 | $109 |
| Xeris Pharmaceuticals, Inc. | 5 | $108 |
| Pfizer | 5 | $96 |
| Dexcom, Inc. | 4 | $81 |
| Medtronic | 3 | $76 |
| Amgen | 4 | $64 |
| Sumitomo Pharma America, Inc. | 3 | $56 |
| Phathom Pharmaceuticals, Inc. | 3 | $47 |
| Axsome Therapeutics, Inc. | 2 | $46 |
| Lundbeck LLC | 2 | $43 |
| Idorsia Pharmaceuticals US Inc | 2 | $31 |
| Sanofi-aventis U.S. LLC | 2 | $29 |
| Genentech USA, Inc. | 2 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Viatris Specialty LLC | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Tactile Systems Technology Inc | 1 | $13 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,489 in reported general payments places this provider in the 90th percentile of 3,007 family providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 62 | $91,242 |
| JardianceEmpagliflozin | 81 | $86,174 |
| Tresiba Flextouch U-200Insulin Degludec | 101 | $79,329 |
| LinzessLinaclotide | 59 | $58,695 |
| EliquisApixaban | 54 | $52,012 |
| TrulicityDulaglutide | 15 | $32,958 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 38 | $26,734 |
| JanuviaSitagliptin Phosphate | 33 | $24,924 |
| MounjaroTirzepatide | 12 | $24,743 |
| Tolvaptan | 13 | $23,370 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 19 | $21,425 |
| XareltoRivaroxaban | 17 | $16,709 |
| FarxigaDapagliflozin Propanediol | 19 | $13,248 |
| EntrestoSacubitril/Valsartan | 12 | $10,296 |
| LevemirInsulin Detemir | 12 | $4,201 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Levemir | $209 | $95,44374 claims |
| Boehringer IngelheimJardiance | $109 | $86,17481 claims |
| AbbVieLinzess, Synthroid | $580 | $60,07882 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $250 | $57,70127 claims |
| PfizerEliquis | $96 | $52,01254 claims |
| AstraZenecaBreztri Aerosphere, Farxiga | $599 | $34,67338 claims |
| GSKTrelegy Ellipta | $299 | $26,73438 claims |
| MerckJanuvia | $123 | $24,92433 claims |
| NovartisEntresto | $166 | $10,29612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,007 family providers in Mississippi.
Other family in Tylertown
- Cinda PerrymanFayette$888K
- Dodie McGeeRaymond$772K
- Gina BurgeJackson$237K
- Christy DavisJackson$208K
- Maranda EversollFlowood$197K
- Dana DelaskiJackson$158K
- Kristin CarrollJackson$158K
- Shannon FryeryOxford$127K
- Nativel CollinsMantachie$73K
- Ashley CocilovaFlowood$72K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.